Precision StemCell: sellings stem cells and treating people as guinea pigs

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an excerpt. Find a link to the full story below.

When journalists and health researchers write about patients seeking access to unproven stem cell interventions, they typically examineinternational travel to clinics located in China, India, Mexico, and elsewhere. In contrast, most domestic companies marketing unlicensed and untested stem cell procedures attract less scrutiny. This oversight is perplexing because numerous U.S. clinics advertise stem cell interventions for amyotrophic lateral sclerosis, multiple sclerosis, dementia, and other diseases. Such businesses promote and provide stem cell-based biologics that are not backed by credible safety and efficacy data and have not been reviewed and approved by the FDA. Precision StemCell, based in Gulf Shores, Alabama, is one example of a domestic clinic marketing stem cell interventions that appear to violate federal regulations.

Read the full story here: Precision StemCell: Selling Stem Cells & Treating Individuals With ALS as Human Guinea Pigs

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend